EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed Securities
EUDA Health Holdings (NASDAQ:EUDA) received a Nasdaq notice dated April 23, 2026, that it failed to maintain a $35.0 million Minimum Market Value of Listed Securities (MVLS) over the last 32 consecutive business days.
Rhea-AI Summary
EUDA Health Holdings (NASDAQ:EUDA) received a Nasdaq notice dated April 23, 2026, that it failed to maintain a $35.0 million Minimum Market Value of Listed Securities (MVLS) over the last 32 consecutive business days.
The MVLS notice does not affect the current listing immediately. The company has a 180-calendar-day compliance period ending October 20, 2026, to close at $35,000,000 or more for ten consecutive business days to regain compliance; failure could lead to delisting proceedings and a possible appeal.
Positive
- Nasdaq provided a 180-calendar-day compliance period ending Oct 20, 2026
- The MVLS notice has no immediate effect on the company’s Nasdaq listing
Negative
- Company failed to meet the $35,000,000 MVLS requirement over 32 business days
- Failure to regain compliance could trigger delisting proceedings
- Company must achieve MVLS ≥ $35,000,000 for ten consecutive business days
Details
News Market Reaction – EUDA
On Apr 27, the day this news came out, EUDA closed 21.09% above the previous close.
Data tracked by StockTitan Argus for the Apr 27 session.
Key Figures
- MVLS requirement
- $35,000,000
- Nasdaq Listing Rule 5550(b)(2) minimum market value of listed securities
- Deficiency period
- 32 consecutive business days
- Period below $35M MVLS before Nasdaq notice
- Compliance period
- 180 calendar days
- Time from April 23, 2026 to regain MVLS compliance
- Compliance deadline
- October 20, 2026
- End of MVLS compliance period set by Nasdaq
- Required MVLS duration
- 10 consecutive business days
- Minimum period MVLS must be ≥ $35M to cure deficiency
- Market cap pre-notice
- $28,826,186
- Market capitalization before MVLS notice publication
- 52-week high
- $86.00
- Pre-news 52-week high price for EUDA
- 52-week low
- $5.26
- Pre-news 52-week low price for EUDA
Historical Context
-
Announced 1-for-20 reverse split to consolidate outstanding ordinary shares.
-
Repurchased and cancelled Streeterville warrant, eliminating up to 2,000,000 dilution shares.
-
Cut Streeterville warrant exercise price to US$2.00, easing forced-exercise price to US$3.00.
-
Convertible loan up to RMB 6 million to fund Shenzhen cGMP facility upgrade.
-
Reduced warrant exercise price from US$6.00 to US$4.00 and lowered forced-exercise trigger.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
market value of listed securities regulatory
delisting regulatory
nasdaq capital market regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
Singapore, April 27, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” and the “Company”) received a written notice (the “MVLS Notice”) from Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) on April 23, 2026, indicating that the Company had failed to maintain a Minimum Market Value of Listed Securities (“MVLS”) of
The MVLS Notice has no immediate effect on the listing of the Company’s securities on Nasdaq and the Company has been provided a period of 180 calendar days from the date of the MVLS Notice, or until October 20, 2026, in which to regain compliance (the “MVLS Compliance Period”). In order to regain compliance with Nasdaq Listing Rule 5550(b)(2), the Market Value of Listed Securities of the Company must close at
In the event that the Company does not regain compliance with Nasdaq Listing Rule 5550(b)(2) within the MVLS Compliance Period, Nasdaq will provide notice to the Company that its listed securities will be subject to delisting. In the event of such notification, the Company may appeal Nasdaq’s determination to delist its securities. However, there can be no assurances that Nasdaq would be able to regain compliance with all applicable requirements for continued listing on the Nasdaq Capital Market.
About EUDA Health Holdings Limited
EUDA Health Holdings Limited (NASDAQ: EUDA) is a Singapore-based leading non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia and China. The Company aims to become a market leader in non-invasive and preventive healthcare, with a strategic focus on the fast-growing longevity sector. Our mission is to address the evolving healthcare needs of over 1.8 billion people across the region which is experiencing significant demographic shifts as more than
Forward-Looking Statements
This document may contain forward-looking statements regarding risks and uncertainties. These statements usually use forward-looking words, such as the words “estimates,” “projected,” “expects,” “envisions,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions). These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside EUDA’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. You should not overly rely on forward-looking statements that are only applicable to the date of publication of this document. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
For investor and media inquiries, please contact:
Christensen Advisory
Christian Arnell
Phone: +852 2117 0861
Email: christian.arnell@christensencomms.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.